At the end of the latest market close, Bionano Genomics Inc. (BNGO) was valued at $5.00. In that particular session, Stock kicked-off at the price of $4.13 while reaching the peak value of $4.89 and lowest value recorded on the day was $3.91. The stock current value is $4.70.
Recently in News on January 11, 2021, Bionano Genomics Announces the Kick-Off of its Next-Generation Cytogenomics Symposium, The Largest Event Yet to Showcase Saphyr’s Utility in Genome Analysis for Genetic Disease and Cancer. Bionano Genomics, Inc. (Nasdaq: BNGO) announced the kick-off its 5-day Next-Generation Cytogenomics Symposium, which starts Monday January 11 and will feature 33 presentations by distinguished Saphyr users from leading hospitals and medical research institutions around the world. The presentations will cover applications of optical genome mapping (OGM) with Saphyr to analyze the genomes of patients with a variety of genetic diseases, blood cancers, solid tumors and repeat disorders as well as the studies supporting validation of clinical assays developed by Saphyr users. The last day of the symposium is dedicated to the study of the genomes of severely ill COVID-19 patients. The event is being held virtually and concludes on January 15, 2021. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Bionano Genomics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $7.24 on 01/04/21, with the lowest value was $3.91 for the same time period, recorded on 01/08/21.
Bionano Genomics Inc. (BNGO) full year performance was 294.00%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Bionano Genomics Inc. shares are logging -35.08% during the 52-week period from high price, and 1780.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.25 and $7.24.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 132622917 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Bionano Genomics Inc. (BNGO) recorded performance in the market was 52.60%, having the revenues showcasing 666.72% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 765.91M, as it employees total of 97 workers.
The Analysts eye on Bionano Genomics Inc. (BNGO)
During the last month, 0 analysts gave the Bionano Genomics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.85, with a change in the price was noted +4.04. In a similar fashion, Bionano Genomics Inc. posted a movement of +615.05% for the period of last 100 days, recording 35,072,926 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BNGO is recording 1.09 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.12.
Technical rundown of Bionano Genomics Inc. (BNGO)
Raw Stochastic average of Bionano Genomics Inc. in the period of last 50 days is set at 62.46%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 62.37%. In the last 20 days, the company’s Stochastic %K was 64.20% and its Stochastic %D was recorded 68.64%.
Considering, the past performance of Bionano Genomics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 52.60%. Additionally, trading for the stock in the period of the last six months notably improved by 786.79%, alongside a boost of 294.00% for the period of the last 12 months. The shares increased approximately by 52.60% in the 7-day charts and went down by 810.50% in the period of the last 30 days. Common stock shares were driven by 666.72% during last recorded quarter.